Skip to content

The Effectiveness of Bupivacaine and Bupivacaine+Dexmedetomidine Combination in Transversus Abdominis Plane* Block

Comparison of the Effectiveness of Bupivacaine and Bupivacaine+Dexmedetomidine Combination in Transversus Abdominis Plane* Block in Colorectal Cancer Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06370949
Acronym
TAP
Enrollment
84
Registered
2024-04-17
Start date
2024-05-01
Completion date
2025-05-01
Last updated
2026-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Colorectal Neoplasms

Keywords

colorectal cancer, colorectal cancer surgery, colorectal neoplasym, transversus abdominis plane, transversus abdominis plane block

Brief summary

Transversus abdominis plane (TAP) block is an anesthesia method that provides somatic analgesia to the anterior and lateral abdominal walls. Thus, TAP block is widely implemented in perioperative management of colorectal cancer patients. Researchers aimed to evaluate the analgesic effectiveness and duration of effect of dexmedetomidine added to bupivacaine in the TAP block applied in colorectal cancer surgeries.

Detailed description

Transversus abdominis plane (TAP) block is an anesthesia method that provides somatic analgesia to the anterior and lateral abdominal walls. With the increasing use of ultrasound guidance during peripheral nerve blocks, trunk blocks such as the transversus abdominis plane (TAP) block are widely used for analgesia after abdominal surgery. The advantages of TAP block include being less invasive than epidural analgesia, lower incidence of hypotension, and shorter hospital stay. Due to these advantages, TAP block has become a widely preferred method. Researchers aimed to evaluate the analgesic effectiveness and duration of effect of dexmedetomidine added to bupivacaine in the TAP block applied in colorectal cancer surgeries. The study will be conducted in a tertiary oncology hospital in Turkey and 84 colorectal cancer patients will be included.

Interventions

DRUGBupivacain

Ultrasonography (USG) guided bilateralTAP block:20 ml %0,25 concentration bupivacain

DRUGbupivacain+dexmedetomidine

Ultrasonography (USG) guided bilateral TAP block: 20 ml %0,25 concentration bupivacain+ 0.5 mcg/kg dexmedetomidine

Sponsors

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* colorectal cancer diagnosis * undergoing colorectal cancer surgery

Exclusion criteria

* allergic reaction to local anesthetics * bleeding anomalies * infection in TAP block area

Design outcomes

Primary

MeasureTime frameDescription
Analgesic effectiveness of bupivacain and bupivacain+dexmedetomidine combination in colorectal cancer surgerypostoperative day twoNumeric Rating Scales of two groups in postoperative period. The numeric rating scale (NRS) is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable"

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORBeyza Seker, MD

Resident MD

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 3, 2026